Hair Thinning

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hair Thinning trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 40 trials

RecruitingPhase 1/2

NCT07317544

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

The goal of this clinical trial is to learn if ABS-201 (a new medication) is safe and tolerable when used to improve hair growth in men and women. The trial wil…

Australia227 participantsStarted 2025-12-03

Treatment: ABS-201 IV Single Dose, Placebo IV

RecruitingNot Applicable

NCT04764357

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

This study is being done to see if the Paxman scalp cooling device can prevent hair loss in pediatric patients receiving chemotherapy for non-cancerous conditio…

United States40 participantsStarted 2021-06-04

Treatment: Paxman Scalp Cooling System, Alopecia Assessments

RecruitingNot Applicable

NCT07563036

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Androgenetic alopecia is a common form of progressive hair loss. This prospective single-arm pre-post interventional study aims to assess tissue Janus Kinase 2…

Egypt25 participantsStarted 2026-02-01

Treatment: Topical Minoxidil 5% Solution, Scalp Punch Biopsy

RecruitingNot Applicable

NCT05612100

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

This study evaluates endocrine therapy-induced alopecia among postmenopausal and premenopausal female patients with breast cancer. Alopecia is one of the most f…

United States170 participantsStarted 2022-07-06

Treatment: Electronic Health Record Review, Questionnaire Administration

RecruitingNot Applicable

NCT07226531

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Alopecia areata (AA) is a chronic, relapsing T-cell mediated autoimmune disease characterized by nonscarring, typically patchy hair loss that affects people of…

United States300 participantsStarted 2025-12-22

Treatment: Ritlecitinib

RecruitingPhase 3

NCT07029828

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

The purpose of this clinical trial is to learn about long-term safety and long-term effects of the study medicine (called ritlecitinib) for the potential treatm…

United States140 participantsStarted 2025-09-10

Treatment: Ritlecitinib higher dose, Ritlecitinib lower dose

All recent trials (100 shown)

Active — Not RecruitingPhase 2

NCT06018428

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Part A is a randomized, double-blind, placebo-controlled, multi-center Proof-of-Concept (POC) Trial in subjects with severe Alopecia Areata. All participants in…

United States75 participantsStarted 2023-09-12

Treatment: bempikibart (ADX-914)

CompletedNot Applicable

NCT05391178

Improving Disease Severity

Phototherapy, including ultraviolet B (UVB) and ultraviolet A (UVA) light, has been used to treat a number of dermatologic conditions. Psoriasis is one of the m…

United States18 participantsStarted 2022-08-09

Treatment: Lumiton yarn sleeve, Lumiton yarn hat

Hair Thinning

Trial phase breakdown

Trial status

Actively recruiting — 40 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

All recent trials (100 shown)

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Improving Disease Severity

Trial phase breakdown

Trial status

Actively recruiting — 40 trials

Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia

Study Of Cold Cap Therapy For Prevention of Hairloss in Pediatric Patients Receiving Chemotherapy For Non-Malignant Indi…

JAK2 Expression in Androgenetic Alopecia Before and After Topical Minoxidil

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

All recent trials (100 shown)

A Phase 2a Proof-of-Concept Trial of Bempikibart (ADX-914) for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Improving Disease Severity

Efficacy and Safety of Millet Seed Extract in Telogen Effluvium Treatment

Facial Papules in Frontal Fibrosing Alopecia (FFA)

Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia

Evaluation of the Performance of a Nutricosmetic on Hair & Scalp in Women and Men After 3 and 6 Months

Penguin Cold Caps in the Prevention of Hair Loss in Breast Cancer Patients

Clinical Study of PRP in the Treatment of Androgenetic Alopecia

Natural History and Pathogenesis of Alopecia in Children and Adults

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata

Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Th…

Phase 3 Study to Evaluate the Efficacy and Safety of Oral Minoxidil (N1087) in Men With Androgenetic Alopecia.

The Effect of Nanofat Injection on Androgenetic Alopecia

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Pharmacokinetic Study of DA-020

Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth

Long-Term PF-06651600 for the Treatment of Alopecia Areata